Global Amoxicillin Market Growth 2025-2031

Global Amoxicillin Market Growth 2025-2031

The global Amoxicillin market size is predicted to grow from US$ 4818 million in 2025 to US$ 5897 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.

Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.

Global Amoxicillin main players include GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, etc., totally accounting for about 48%. Europe is the largest market, with a share over 29%. As for the types of products, it can be divided into capsule, tablet and others. The most common product is capsulee, holding a share over 80%. In terms of applications, it is widely used in hospital pharmacy, retail pharmacy and online pharmacy. The most application is retail pharmac, with a share over 62%.

LP Information, Inc. (LPI) ' newest research report, the “Amoxicillin Industry Forecast” looks at past sales and reviews total world Amoxicillin sales in 2024, providing a comprehensive analysis by region and market sector of projected Amoxicillin sales for 2025 through 2031. With Amoxicillin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amoxicillin industry.

This Insight Report provides a comprehensive analysis of the global Amoxicillin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amoxicillin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amoxicillin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amoxicillin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amoxicillin.

This report presents a comprehensive overview, market shares, and growth opportunities of Amoxicillin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Capsule
Tablet
Others

Segmentation by Application:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GSK
Novartis
Centrient Pharma
Teva
Mylan
Cipla
NCPC
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma
Dr. Reddy
HPGC
Aurubindo
Meiji Holdings

Key Questions Addressed in this Report

What is the 10-year outlook for the global Amoxicillin market?

What factors are driving Amoxicillin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Amoxicillin market opportunities vary by end market size?

How does Amoxicillin break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.